Flavonoid Intake and Eye Health

Journal of Nutrition in Gerontology and Geriatrics

Volumn 31, Issue 3, 2012, Pages 254-268

  Milbury, Paul E ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

cataract; eye health; flavonoids; glaucoma; macular degeneration; night vision impairment; retinopathy; vision

Indexed keywords

FLAVONOID; PLANT EXTRACT;

ARTICLE; DRUG EFFECT; EYE; HUMAN; PHYTOTHERAPY; VISION; VISUAL DISORDER;

EYE; FLAVONOIDS; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; VISION DISORDERS; VISION, OCULAR;

EID: 84865076196     PISSN: 21551197     EISSN: 21551200     Source Type: Journal    
DOI: 10.1080/21551197.2012.698221     Document Type: Article

References (69)

1. Ganley JP, Roberts J. Eye Conditions and Related Need for Medical Care Among Persons 1-74 Years of Age, United States, 1971-72. Hyattsville, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Center for Health Statistics. DHHS publication no. 83-1678; 1983.
2. Klaver CC, Wolfs RC, Vingerling JR, Hofman A, de Jong PT. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998; 116: 653-8.
3. Sauberlich HE. A history of scurvy and vitamin C. In: Packer L, Fuchs J, eds. Vitamin C in Health and Disease., 1st ed. New York: Marcel Decker; 1997: 1-24.
4. Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr. 1999; 69: 1086-107.
5. Rusznyak S, Szent-Györgyi A. Vitamin P: flavonols as vitamins. Nature. 1936; 138: 27.
6. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr. 2000; 130: S2073-85.
7. Middleton E Jr, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev. 2000; 52: 673-751.
8. Hollman PC, Katan MB. Bioavailability and health effects of dietary flavonols in man. Arch Toxicol Suppl. 1998; 20: 237-48.
9. Kühnau J. The flavonoids: a class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet. 1976; 24: 117-91.
10. Hertog MGL, Hollman PCH, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer. 1993; 20: 21-9.
11. Milbury PE, Graf B, Curran-Celentano JM, Blumberg JB. Bilberry (Vaccinium myrtillus) anthocyanins modulate heme oxygenase-1 and glutathione S-transferase-pi expression in ARPE-19 cells. Invest Ophthalmol Vis Sci. 2007; 48: 2343-9.
12. Milbury PE. Transport of flavonoids into the brain. In: Packer L, Sies H, Eggersdorfer M, Cadenas E, eds. Micronutrients and Brain Health., 1st ed. Boca Raton: CRC Press; 2009:265-79.
13. Lobo CL, Bernardes RC, Cunha-Vaz JG. Alterations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes. Arch Ophthalmol. 2000; 118: 1364-9.
14. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans, II: Review of 93 intervention studies. Am J Clin Nutr. 2005; 81: 243S-55S.
15. Crespy V, Morand C, Besson C, Cotelle N, Vezin H, Demigne C, Remesy C. The splanchnic metabolism of flavonoids highly differed according to the nature of the compound. Am J Physiol Gastrointest Liver Physiol. 2003; 284: 980-8.
16. Shahidi F, Wanasundara PKJ. Phenolic antioxidants. Crit Rev Food Sci Nutr. 1992; 32: 67-103.
17. Wu X, Beecher GR, Holden JM, Haytowitz DB, Gebhardt SE, Prior RL. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem. 2006; 54: 4069-75.
18. Manach C, Williamson G, Morand C, Scalbert A, Remesy C. Bioavailability and bioefficacy of polyphenols in humans, I: Review of 97 bioavailability studies. Am J Clin Nutr. 2005; 81: 230S-42S.
19. Kalt W, Blumberg J, McDonald J, Vinqvist-Tymchuk M, Fillmore S, et al. Identification of anthocyanins in the liver, eye, and brain of blueberry-fed pigs. J Agric Food Chem. 2008; 56: 705-12.
20. Matsumoto H, Nakamura Y, Iida H, Ito K, Ohguro H. Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues. Exp Eye Res. 2006; 83: 348-56.
21. Milbury PE, Kalt W. Xenobiotic metabolism and berry flavonoid transport across the blood-brain barrier. J Agric Food Chem. 2010; 58: 3950-6.
22. West AL, Oren GA, Moroi SE. Evidence for the use of nutritional supplements and herbal medicines in common eye diseases. Am J Ophthalmol. 2006; 141: 157-66.
23. Age-related Eye Disease Study Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E and beta carotene for age-related cataract and vision loss: AREDS report no. 9. Arch Ophthalmol. 2001; 119: 1439-52.
24. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000; 45: 115-34.
25. Lebuisson DA, Leroy L, Rigal G. Treatment of senile macular degeneration with Ginkgo biloba extract: a preliminary double-blind drug vs. placebo study. Presse Med. 1986; 15: 1556-8.
26. Nishida S, Satoh H. Comparative vasodilating actions among terpenoids and flavonoids contained in Ginkgo biloba extract. Clin Chim Acta. 2004; 339: 129-33.
27. Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R. Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther. 1999; 15: 233-40.
28. Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003; 110: 359-64.
29. Treveris P. Grete herbal, anonymous herbal. London: Peter Treveris; 1526. Current copies and microfilms at the University of Texas at Austin, the Huntington, and the British Royal Horticultural Society.
30. Detre Z, Jellinek H, Miskulin M, Robert AM. Studies on vascular permeability in hypertension: action of anthocyanosides. Clin Physiol Biochem. 1986; 4: 143-9.
31. Liu Y, Song X, Han Y, Zhou F, Zhang D, et al. Identification of anthocyanin components of wild Chinese blueberries and amelioration of light-induced retinal damage in pigmented rabbit using whole berries. J Agric Food Chem. 2011; 59: 356-63.
32. Losada M, Alio JL. Malondialdehyde serum concentration in type 1 diabetic with and without retinopathy. Doc Ophthalmol. 1996-1997; 93: 223-9.
33. Nicolle E, Souard F, Faure P, Boumendjel A. Flavonoids as promising lead compounds in type 2 diabetes mellitus: molecules of interest and structure-activity relationship. Curr Med Chem. 2011; 18: 2661-72.
34. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352: 837-53.
35. DeFuria J, Bennett G, Strissel KJ, Perfield JW IInd, Milbury PE, et al. Dietary blueberry attenuates whole-body insulin resistance in high fat-fed mice by reducing adipocyte death and its inflammatory sequelae. J Nutr. 2009; 139: 1510-6.
36. Perossini M, Guidi G, Chiellini S, Siravo D. Diabetic and hypertensive retinopathy therapy with Vaccinium myrtillus anthocyanosides (Tegens). A double-blind placebo-controlled clinical trial. Ann Ottal Clin Ocul. 1987; 113: 1173-90.
37. Scharrer A, Ober M. Anthocyanosides in the treatment of retinopathies. Klin Monatabl Augenheilkd. 1981; 178: 386-9.
38. Bessière E. Étude clinique de flavan, deuxieme partie: Ophtalmologie. Paris: Informations Médicales Laboratoires Millot; 1970.
39. Magnard G, Franck JP, Dorne PA. Intéret du tetrahydroxy flavane diol en ophtalmologie en particulier dans le rétinopathie diabétique. Lyon Med. 1970; 4: 1-18.
40. Leydhecker W. Zur medicamentösen Behandlung der diabetischen Retinopathie. Study report. Würzburg, Germany: The Ophthalmology Department of the University Clinic of Würzburg; 1986.
41. Spadea L, Balestrazzi E. Treatment of vascular retinopathy with Pycnogenol. Phytother Res. 2001; 15: 219-23.
42. Plantorgan Arzneimittel. Pygnoforton Bei Diabetischer Retinopathy. Plantorgan study report, 1988. And detailed study cited in: Schonlau F, Rohdewald P. Pycnogenol for diabetic retinopathy. A review. Int Ophthalmol. 2001; 24: 161-71.
43. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120: 701-13.
44. Coleman AL, Stone KL, Kodjebacheva G, Yu F, Pedula KL, et al. Study of Osteoporotic Fractures Research Group: Glaucoma risk and the consumption of fruits and vegetables among older women in the study of osteoporotic fractures. Am J Ophthalmol. 2008; 145: 1081-9.
45. Steigerwalt RD, Gianni B, Paolo M, Bombardelli E, Burki C, Schönlau F. Effects of Mirtogenol on ocular blood flow and intraocular hypertension in asymptomatic subjects. Mol Vis. 2008; 14:1288-92.
46. Chung HS, Harris A, Kristinsson JK, Ciulla TA, Kagemann C, Ritch R. Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther. 1999; 15: 233-40.
47. Quaranta L, Bettelli S, Uva MG, Semeraro F, Turano R, Gandolfo E. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma. Ophthalmology. 2003; 110: 359-62.
48. Wimpissinger B, Berisha1 F, Garhoefer G, Polak K, Schmetterer L. Influence of Ginkgo biloba on ocular blood flow. Acta Ophthalmol Scand. 2007; 85: 445-9.
49. Pollreisz A, Schmidt-Erfurth U. Diabetic cataract-pathogenesis, epidemiology and treatment. J Ophthalmol. 2010; 2010: 608-751.
50. Obrosova IG, Chung SS, Kador PF. Diabetic cataracts: mechanisms and management. Diabetes Metab Res Rev. 2010; 26: 172-80.
51. Tavani A, Negri E, Vecchia CL. Food and nutrient intake and risk of cataract. Ann Epidemio. 1996; 6: 41-6.
52. Jacques PF, Chylack LT. Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr. 1991; 53: 352S-5S.
53. Stefek M. Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract. Interdiscip Toxicol. 2011; 4: 69-77.
54. Robertson JM, Donner AP, Trevithick JR. A possible role for vitamins C and E in cataract prevention. Am J Clin Nutr. 1991; 53: 346S-51S.
55. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002; 76: 560-8.
56. Varma SD, Mizuno A, Kinoshita JH. Diabetic cataracts and flavonoids. Science. 1977; 195: 205-6.
57. Lu M-P, Wang R, Song X, Chibbar R, Wang X, Wu L, Meng QH. Dietary soy isoflavones increase insulin secretion and prevent the development of diabetic cataracts in streptozotocin-induced diabetic rats. Nutr Res. 2008; 28: 464-71.
58. Nakano M, Orimo N, Katagiri N, Tsubata M, Takahashi J, Van Chuyen N. Inhibitory effect of astraxanthin combined with Flavangenol on oxidative stress biomarkers in streptozotocin-induced diabetic rats. Int J Vitam Nutr Res. 2008; 78: 175-82.
59. Yoshizawa T, Wald G. Pre-lumirhodopsin and the bleaching of visual pigments. Nature. 1963; 197: 1279-86.
60. Tachibanaki S, Imai H, Mizukami T, Okada T, Imamoto Y, et al. Presence of two rhodopsin intermediates responsible for transducin activation. Biochemistry. 1997; 36: 14173-9.
61. Curcio CA, Millican CL, Allen KA, Kalina RE. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Investigative Ophthalmology & Visual Science. 1993; 34: 3278-96.
62. Jackson GR, Owsley C, Cordle EP, Finley CD. Aging and scotopic sensitivity. Vision Research. 1998; 38: 3655-62.
63. Lamb TD, Pugh EN Jr. Dark adaptation and the retinoid cycle of vision. Prog Retin Eye Res. 2004; 23: 307-80.
64. Bird AC. Bruch's membrane change with age. Br J Ophthalmol. 1992; 763:166-8.
65. Owsley C, McGwin G, Jackson GR, Heimburger DC, Piyathilake CJ, et al. Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy. Invest Ophthalmol Vis Sci. 2006; 47: 1310-8.
66. Matsumoto H, Nakamura Y, Tachibanaki S, Kawamura S, Hirayama M. Stimulatory effect of cyanidin 3-glycosides on the regeneration of rhodopsin. J Agric Food Chem. 2003; 51: 3560-3.
67. Canter P, Ernst E. Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision-a systematic review of placebo controlled trials. Surv Ophthalmol. 2004; 49: 38-50.
68. Jayle GE, Aubert L. Action des glucosides d'anthocyanes sur la vision scotopique et mesopique du suject normal. Therapie. 1964; 19: 171-5.
69. Muth ER, Laurent JM, Jasper P. The effect of bilberry nutritional supplementation on night visual acuity and contrast sensitivity. Alternative Medicine Review. 2000; 5: 164-73.